...
首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers.
【24h】

The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers.

机译:切除类型对N1非小细胞肺癌患者生存的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Complete resection is the therapy of choice in non-small-cell lung cancer (NSCLC). There is no agreement on the type of resection, especially when interlobar N1 disease is present. The present study explored the effect of the type of resection on survival in the presence of N1 disease. METHOD: Medical records of 195 patients with NSCLC who underwent resection between 1998 and 2006 and whose histopathological examination showed N1 disease were reviewed retrospectively. This study included 162 patients with T status of T1, T2 or T3, who had complete resection (excluding superior sulcus tumours). The patients were divided into three groups, namely hilar N1 (n=15, 9.3%), interlobar N1 (N1-i) (n=54, 33.3%) and lobar N1 (n=93, 57.4%). Frequency comparisons were carried out by chi-square test. Survival rates were calculated by the Kaplan-Meier method and compared by log-rank test after patients who had operative mortality (n=10, 6.2%) were excluded. RESULTS: Seventy-seven patients (47.5%) had lobectomy, 14 (8.6%) had bilobectomy (BL) and 71 (43.8%) had pneumonectomy (PN). Twenty-one of these patients (13.0%) had sleeve lobectomy and 19 had (11.7%) additional interventions (such as resection of the diaphragm or thoracic wall). Among all N1 patients, 5-year survival rate was 56.9% in patients who had BL or PN and 46.8% in patients who had lobectomy, a difference not statistically significant (p=0.09). Similarly, there was no significant difference between patients who had sleeve resection and PN (p=0.58). The type of resection was not found related to survival in the presence of interlobar (p=0.75). Similarly, type of resection was not significantly associated with survival in patients with hilar N1 (p=0.86). CONCLUSION: Those who had PN or BL had a higher survival rate, which was statistically insignificant. Further studies are required to determine whether or not the type of resection should be changed as a result of N1 only.
机译:目的:完全切除是非小细胞肺癌(NSCLC)的首选治疗方法。对于切除类型尚无共识,尤其是在存在叶间N1疾病时。本研究探讨了存在N1疾病时切除类型对生存的影响。方法:回顾性分析1998年至2006年间行手术切除的195例NSCLC患者的病历,其组织病理学检查显示N1病。该研究包括162例T1,T2或T3状态的T型患者,这些患者已完全切除(不包括上沟肿瘤)。将患者分为三组,即肺门N1(n = 15,9.3%),门间N1(N1-i)(n = 54,33.3%)和门N1(n = 93,57.4%)。通过卡方检验进行频率比较。存活率通过Kaplan-Meier方法计算,并在排除具有手术死亡率(n = 10,6.2%)的患者后,通过对数秩检验进行比较。结果:77例(47.5%)患者接受了肺叶切除术,14例(8.6%)接受了双叶切除术(BL),71例(43.8%)进行了肺切除术(PN)。这些患者中有21名(13.0%)进行了袖肺叶切除术,其中19名(11.7%)进行了其他干预(例如the肌或胸壁切除术)。在所有N1患者中,BL或PN患者的5年生存率分别为56.9%和肺叶切除术患者的46.8%,差异无统计学意义(p = 0.09)。同样,进行袖套切除的患者和PN之间也无显着差异(p = 0.58)。未发现切除类型与存在门叶间的生存相关(p = 0.75)。同样,肝门N1患者的切除类型与生存率无显着相关性(p = 0.86)。结论:PN或BL患者的生存率较高,在统计学上无统计学意义。需要进一步研究以确定是否应仅由于N1改变切除类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号